Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors
|
|
- Lynn Perry
- 6 years ago
- Views:
Transcription
1 Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors This educational call is sponsored by the Enterprise Risk Management Task Force. Thursday, April 11, :00 am 12:00 pm (Eastern Time) Presenter: Robyn Diaz St. Jude Children s Research Hospital Memphis, TN robyn.diaz@stjude.org 1
2 Overview Prescription Drug Abuse in the U.S. What is Doctor Shopping? Uniform Narcotic Drug Act Uniform Controlled Substances Act State Doctor Shopping Laws Prescription Monitoring Programs Managing Risks 2
3 Prescription Drug Abuse in the U.S. Increase in accidental opioid overdoses Prescription drug abuse increasingly common with teenagers Increasing number of overdose fatalities attributed to overprescribing 3
4 What is Doctor Shopping? Patient obtaining controlled substances from multiple health care practitioners without the prescribers knowledge of the other prescriptions Usually going from doctor to doctor (or to ER) in a short period of time Doctor shopping + overprescribing = dangerous combination 4
5 CME Requirements TN - Requires every physician to complete a 1 hour course in prescribing practices as part of mandatory 40- hour CME requirements every 2 years. OK has similar requirement to TN CA, WV both have pain management CME requirements 5
6 Uniform Narcotic Drug Act (1932) No person shall obtain or attempt to obtain a narcotic drug, or procure or attempt to procure the administration of a narcotic drug, (a) by fraud, deceit, misrepresentation, or subterfuge; or (b) by the forgery or alteration of a prescription ; or (c) by the concealment of a material fact; or (d) by the use of a false name or false address. (2) Information communicated to a physician in an effort unlawfully to procure a narcotic drug shall not be deemed a privileged communication. 6
7 Uniform Controlled Substances Act (1970) A person may not knowingly or intentionally acquire or obtain possession of a controlled substance by misrepresentation, fraud, forgery, deception, or subterfuge 7
8 State Doctor Shopping Laws CDC is excellent resource on state laws: g/laws/dr_shopping.html Don t forget Medicaid-specific provisions 8
9 Look at your state law: TN Example T.C.A T.C.A TN: Actual knowledge that a person has knowingly, willfully and with intent to deceive obtained or attempted to obtain a controlled substance -- Must report within 5 business days to local law enforcement. 9
10 Prescription Monitoring Programs 42 States currently have an operational PMP Pharmacists in states where monitoring programs exist are required to report controlled substance prescriptions. Prescribers may (and in some states, must) check the database before prescribing, or run regular DEA reports Alliance of States with Prescription Monitoring Programs: 10
11 TN CSMD 1/1/13 - Prescribers with DEA numbers who provide direct care to patients in Tennessee for more than 15 days per year had to register 4/1/13- Prescribers must check the database before prescribing an opioid or a benzodiazepine as a new course of treatment lasting more than 7 days, and at least annually thereafter Exceptions 11
12 Challenges of Databases Typically only authorized by law to run a search of your patient s information, not of a patient s family member. If you work in a multi-state/border area, you may have multiple state databases to check. Pharmacies that ship to multiple states have reporting requirements to multiple states. Operational burdens 12
13 Why Should Healthcare Providers be Concerned? Patient Harm Missed opportunity to treat possible addiction Liability risk (individual prescriber and institution) Reputational risk Overprescribing is of interest to law enforcement State licensing board actions (reportable to NPDB) DEA actions (reportable to NPDB) Criminal actions 13
14 Managing Risks Document exam and assessment before prescribing Keep good records Don t overprescribe (small quantities when possible) Discuss with patients importance of not sharing medications and of potential addiction 14
15 Managing Risks, Continued Look for red flags Pressure to prescribe a particular opioid Multiple increases for requests in pain meds No clear clinical explanation for pain level Rejects treatment aside from pain medications Personal or family history of substance abuse 15
16 Managing Risks, Continued Use pain management contract No alcohol or recreational substances Take all pain medications exactly as prescribed Do not attempt to obtain pain medications from another provider Require patient to use one pharmacy and bring bottles of pain medications to all visits Pain may be re-checked frequently Drug-screening tests? 16
17 Questions? 17
18 Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors 2013 is published by the American Health Lawyers Association. All rights reserved. No part of this publication may be reproduced in any form except by prior written permission from the publisher. Printed in the United States of America. Any views or advice offered in this publication are those of its authors and should not be construed as the position of the American Health Lawyers Association. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is provided with the understanding that the publisher is not engaged in rendering legal or other professional services. If legal advice or other expert assistance is required, the services of a competent professional person should be sought from a declaration of the American Bar Association 18
We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit
We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit Objectives Provide a background of the law enforcement initiative with the current heroin problem and how we
More informationControlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control
Controlled Substance Prescribing and Diversion Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control In 2010, approximately 38,329 unintentional drug overdose deaths occurred in the United States,
More information4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update
Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov
More informationLaw Enforcement and the Prescriber Enforcement Action Protocol
Law Enforcement and the Prescriber Enforcement Action Protocol Ken Clark U.S. Department of Justice United States Attorney s Office District of Maryland Opioid Abuse Approx 2.6 fatal overdoses per day
More informationThe Wisconsin Prescription Drug Monitoring Program
The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationWHAT YOU NEED TO KNOW TO ABOUT AB 474
WHAT YOU NEED TO KNOW TO ABOUT AB 474 PRESENTED BY: NEVADA STATE BOARD OF OSTEOPATHIC MEDICINE 2275 Corporate Circle, Suite 210 Henderson, NV 89074 702-732-2147 Fax 702-732-2079 Web Site: www.bom.nv.gov
More informationPrescribing Controlled Substances and the PDMP
Prescribing Controlled Substances and the PDMP Jack Kabazie, MD System Director Division of Pain Medicine Allegheny Health Network Program Director Pain Medicine Fellowship Prescribing Guidelines for Pennsylvania
More informationThe Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.
The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp
More informationCalifornia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationSWALLOWING THE WRONG PILL Criminal Drug Diversion By Physicians and Other Medical Professionals A Prosecutor s Perspective
SWALLOWING THE WRONG PILL Criminal Drug Diversion By Physicians and Other Medical Professionals A Prosecutor s Perspective I am a federal prosecutor in Seattle, Washington. Within the last two years, I
More informationVermont. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Vermont Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of
More informationNYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.
NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement May 2, 2018 1 May 2, 2018 2 Bureau Overview May 2, 2018 3 HISTORY 1850--Bureau
More informationCurbing Prescription Drug Abuse in Medicaid
Curbing Prescription Drug Abuse in Medicaid Joint Legislative Health Care Oversight Committee October 12, 2010 Dr. Lisa Weeks, BSPharm, PharmD Pharmacy and Ancillary Services Division of Medical Assistance
More informationLegal Issues in Opioid Prescribing
Legal Issues in Opioid Prescribing Joanne L. Martin, J.D. Legal Counsel Mayo Clinic Rochester, Mn 2015 MFMER slide-1 Conflict of Interest I have no relevant financial relationships to disclose I will not
More information4/10/2016. Legal & Policy Approaches to Reducing Opioid Poisonings. Overview. Background. Health Directors Legal Conference April 19, 2016
Legal & Policy Approaches to Reducing Opioid Poisonings Health Directors Legal Conference April 19, 2016 Corey Davis Network for Public Health Law Overview Fatal opioid overdose is at epidemic levels Many
More informationD. Todd Bess, PharmD 1
s Program as a Tool to Improve Patient Care and Fight the Drug Epidemic D. Todd Bess, Pharm.D. Director April 12, 2018 Disclosure Information I have no financial relationships to disclose. I will not discuss
More informationArkansas Prescription Monitoring Program
Arkansas Prescription Monitoring Program FY 2017 Second Quarter Report October December 2016 Arkansas Prescription Monitoring Program Quarterly Report October December, Fiscal year 2017 Act 304 of 2011
More information11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?
Where Can I Find A Copy of the PDMP Law? Alabama Uniform Controlled Substances Act Code of Alabama 1975 20-2- (Article 10) -210 through 220 and Rules 420-7-2-.11 through.13 1 Why Was the Law Established?
More informationMedicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain
More informationMaternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015
Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples
More informationProject Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data
Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Presented to Bureau of Justice Assistance Harold Rogers Prescription
More informationPresentation Overview
Navigating the Changing Regulatory Enforcement Landscape Relating to Opioids Anna M. Grizzle Tizgel K.S. High Jerry Williamson, M.D. Presentation Overview Recent Enforcement Actions Physician s Perspective
More informationCDC s Approach to Addressing the Opioid Overdose Epidemic
CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths
More informationPrescription Monitoring Program (PMP)
06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid
More informationIllinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program
Illinois Prescription Monitoring Program Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program Agenda Provide an overview of the Illinois Prescription Monitoring Program
More informationTennessee. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationModel State Electronic Prescription Monitoring Program Legislation
Model State Electronic Prescription Monitoring Program Legislation Produced by the University of Wisconsin s Pain & Policy Studies Group (PPSG) in partnership with the American Cancer Society Cancer Action
More informationRhode Island. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationLiability, Informed Consent, and Risk Management 15 Thoughts for Pain Management Physicians
Liability, Informed Consent, and Risk Management 15 Thoughts for Pain Management Physicians Click to edit Master title style Presented by: Scott Becker, JD, CPA, Partner, Publisher Becker Healthcare 14th
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More informationPrescribing and Dispensing Drugs
STANDARDS & GUIDELINES Prescribing and Dispensing Drugs TABLE OF CONTENTS Standards and guidelines inform practitioners and the public of CDSBC s expectations for registrants. This document primarily contains
More informationOutline. Decreasing total opioid prescriptions Decreasing benzodiazepine and opioid co-prescription. Increasing community awareness of opioid risks
RxSafe Marin overview Outline Safe Prescribing Guidelines Decreasing total opioid prescriptions Decreasing benzodiazepine and opioid co-prescription Increasing community awareness of opioid risks Increasing
More informationPharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.
Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education
More informationControlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System
Controlled Substance Prescribing: A Physician s Guide Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Objectives Review schedules of controlled substances and their propensity for
More information[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016
[First Reprint] ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 0 Sponsored by: Assemblyman DANIEL R. BENSON District (Mercer and Middlesex) Assemblywoman VALERIE VAINIERI HUTTLE
More informationPrescription Monitoring Program Center of Excellence at Brandeis. Drug-Related Deaths in Virginia: Medical Examiner Use of PMP Data
Prescription Monitoring Program Center of Excellence at Brandeis Notes from the Field NF 2.6 Drug-Related Deaths in Virginia: Medical Examiner Use of PMP Data December, 2011 This project was supported
More informationApril 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director
More information1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0
1 HB37 2 188862-1 3 By Representative Williams (JD) 4 RFD: Health 5 First Read: 09-JAN-18 6 PFD: 11/28/2017 Page 0 1 188862-1:n:11/16/2017:PMG/tj LSA2017-3516 2 3 4 5 6 7 8 SYNOPSIS: This bill would establish
More informationIllinois Heroin Crisis Act and Family Physicians. October 14, 2015 Hinsdale Family Medicine Residency Faculty Development Program
Illinois Heroin Crisis Act and Family Physicians October 14, 2015 Hinsdale Family Medicine Residency Faculty Development Program Your speaker s disclosures Executive vice president, Illinois Academy of
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More informationTeaching Objectives Describe the balance a that must be sought in the treatment of pain and the prevention of drug diversion. Discuss regulatory polic
Preventing Controlled Substance Diversion David B. Brushwood, R.Ph.,., J.D. Professor of Pharmaceutical Outcomes & Policy The University of Florida Teaching Objectives Describe the balance a that must
More informationTHE OPIOID EPIDEMIC IN PENNSYLVANIA
THE OPIOID EPIDEMIC IN PENNSYLVANIA TOP TEN LEGAL CONSIDERATIONS FOR HEALTH CARE PROVIDERS PBI 24 th Annual Health Law Institute March 14, 2018 Douglas Moak Counsel Independence Blue Cross Retail opioid
More informationMorrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence
Morrison County Community-Based Care Coordination Our Core Values Reverence Integrity Compassion Excellence Community Based Care Coordination Project The goal is to mitigate the need for, overuse of, and
More information9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort
DEA FIELD OFFICES IN FLORIDA Miami Divisional Office David Wickey, GS 954-306-4650 Orlando District Office Linda Stocum, GS 407-333-7046 Tampa District Office Amie Hickerson, GS 813-287-5160 Tallahassee/Jacksonville
More informationHarold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD
Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD National Epidemic Highlighted numerous studies/media reports State Epidemic Highlighted
More informationACCG Mental Health Summit
ACCG Mental Health Summit Sheila Pierce, Opioid Program Coordinator Director, Prescription Drug Management Program Discussion 1. Overview Opioid Problem in GA - Video 2. DPH Opioid Program 3. Priorities
More informationC. No employee shall report to work or remain on duty while having a detectable blood alcohol concentration.
1 Series 3000 Personnel Section 3100 General Provisions Policy 3101 Drug Free Work Place File: 3101 3101.1 STATEMENT OF PURPOSE: The WV Board of Education and the Harrison County Board of Education recognize
More information& CONSUMES 80% 5% OF THE WORLD S POPULATION 5/19/2017. New Naloxone Regulations & the Importance of Using PRESCRIPTION DRUG ABUSE EPIDEMIC
New Naloxone Regulations & the Importance of Using the PMP Yenh Long PharmD, BCACP Program Administrator Nevada Prescription Monitoring Program May 17, 2017 PRESCRIPTION DRUG ABUSE EPIDEMIC The United
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alaska Requires adoption of regulations that provide that a practitioner query the PDMP prior to dispensing, prescribing, or administering a Sch. II or III controlled substance; query is not required for
More informationEvaluation of the N.C. Prescription
Evaluation of the N.C. Prescription Drug Monitoring Program 2013 National Meeting of the Safe States Alliance and SAVIR MarianaGarrettson Garrettson, MPH Chris Ringwalt, DrPH UNC Injury Prevention Research
More informationSENATE FILE NO. SF0042. Sponsored by: Joint Judiciary Interim Committee A BILL. for. AN ACT relating to public health and safety; creating the
0 STATE OF WYOMING LSO-000 SENATE FILE NO. SF00 Opiate overdose emergency treatment. Sponsored by: Joint Judiciary Interim Committee A BILL for AN ACT relating to public health and safety; creating the
More informationAHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion
Fraud and Compliance Forum, October 2017. Click here to access audio. AHLA X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Michelle Bergholz Frazier Senior Vice President,
More informationWhite Collar Courier: Delivering News and Providing Guidance in White Collar Matters
White Collar Courier: Delivering News and Providing Guidance in White Collar Matters By Adam Overstreet The new DOJ initiative aggressively investigating and prosecuting pain management practitioners Part
More informationNM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 218 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau
More informationNaloxone Access Statutes
Naloxone Access Statutes Research current through August 30, 2015 This project was supported by Grant No. G15599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions
More informationLessons from the First Year Implementing A Local Prescription Drug Abuse Coalition. Matt Willis, MD MPH Public Health Officer Marin County
Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition Matt Willis, MD MPH Public Health Officer Marin County What can we do as a community to prevent prescription drug misuse
More informationCardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention
Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention The people of Cardinal Health care deeply about the devastation opioid abuse has caused American families and communities
More informationPennsylvania Prescription Drug Monitoring Program Trends,
DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly
More informationNC General Statutes - Chapter 90 Article 5E 1
Article 5E. North Carolina Controlled Substances Reporting System Act. 90-113.70. Short title. This Article shall be known and may be cited as the "North Carolina Controlled Substances Reporting System
More informationA Bill Regular Session, 2015 SENATE BILL 717
Stricken language would be deleted from and underlined language would be added to present law. 0 State of Arkansas 0th General Assembly As Engrossed: S// H// A Bill Regular Session, SENATE BILL By: Senator
More informationLegal Aspects of Opioid Management
GW GARFUNKEL WILD, P.C. ATTORNEYS AT LAW Legal Aspects of Opioid Management June 12, 2017 Andrew E. Blustein Vice Chairman of Garfunkel Wild, P.C. Great Neck, NY (516) 393-2200 Hackensack, NJ (201) 883-1030
More informationReview of Controlled Drugs and Substances Act
Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A
More informationNew Policy Changes Designed to Combat the Opioid Epidemic
New Policy Changes Designed to Combat the Opioid Epidemic Alan W. Obringer, RPh, CPh, CGP President of Guardian Pharmacy of Orlando and Brad Kile, PhD President of Dumbarton Group, LLC Objectives List
More informationAddressing the Opioid Epidemic in Tennessee
Addressing the Opioid Epidemic in Tennessee A Multidisciplinary Approach Melissa McPheeters, PhD, MPH Director, Informatics and Public Health Analytics 26 108 733 *Source: CDC References Centers for
More informationUniversity of Pittsburgh
Learning Objectives Participants will be able to: Associate the history of prescription drug use in America with the current trend of prescription drug abuse; Differentiate between the three most commonly
More informationUtah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
More informationNew Mexico. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationProvider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting
Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting Baltimore, MD April 5, 2011 Massachusetts Department of Public Health MA Prescription Monitoring Program
More informationISSUING AGENCY: Regulation and Licensing Department - NM Board of Osteopathic Medical Examiners.
Code of New Mexico Rules Title 16. Occupational and Professional Licensing Chapter 17. Osteopathic Medicine and Surgery Practitioners Part 5. Prescribing and Distribution of Controlled Substances 16.17.5.
More informationThe Role of the PDMP: Foundational Knowledge and Best Practices
The Role of the PDMP: Foundational Knowledge and Best Practices Brent I. Fox, PharmD, PhD Health Outcomes Research and Policy Harrison School of Pharmacy Auburn University DISCLOSURE I, Brent Fox, have
More informationPDMP Tools to Identify Red Flag Situations
PDMP Tools to Identify Red Flag Situations Prescription Drug Monitoring Programs CBI Baltimore, MD February 7, 2017 Grant Carrow, Ph.D. Project Consultant The Heller School for Social Policy and Management
More informationMinnesota. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Minnesota Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationMedicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross and Blue Shield Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management.
More informationCLINICAL POLICY Clinical Policy: Extended Release Opioid Analgesics
Reference Number: AZ.CP.PMN.97 Effective Date: 02.11 Last Review Date: 02.18 Line of Business: Medicaid- AHCCCS Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationReport to the Legislature: Unsolicited Reporting Criteria Established and Process Review MN Prescription Monitoring Program
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Minnesota Board of
More informationMARYLAND BOARD OF PHARMACY
MARYLAND BOARD OF PHARMACY CONTRACEPTION REGULATIONSAnd Other Legislative Initiatives THE ROAD FROM CONCEPTUALIZATION TO IMPLEMENTATION Deena Speights-Napata Executive Director Maryland Board of Pharmacy
More informationTN Opioid Program. Erica Schlesinger, Pharm.D
TN Opioid Program Erica Schlesinger, Pharm.D Nothing to disclose Disclosures TN Together Governor Haslam s Plan Prevention Establishes limits, decreases supply and dosage of prescription opioids Limits
More informationNew Guidelines for Prescribing Opioids
New Guidelines for Prescribing Opioids Keeping Your Claimants Safe Presented by: Dr. Mitch Freeman, Pharm.D. Chief Clinical Officer, Pharmacy Solutions Agenda The Opioid Challenge Today How We Got Here
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationUTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB)
UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB) Harold Rogers Prescription Drug Monitoring Program National Meeting Washington, D.C. August 17 August 19 th, 2016 Marvin H. Sims, C.S. DataBase Administrator
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)
H GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH0-MGfa-H* (01/) H.B. Mar, HOUSE PRINCIPAL CLERK D Short Title: Strengthen Opioid Misuse Prevention (STOP)Act. (Public) Sponsors: Referred to:
More informationH 5381 S T A T E O F R H O D E I S L A N D
LC00 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - THE HEALING ART OF ACUPUNCTURE Introduced By: Representative
More informationSafe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland
Safe Prescribing and Dispensing of Controlled Drugs Joint Guidance Medical Council and Pharmaceutical Society of Ireland Purpose of this Guidance Purpose of this Guidance This resource aims to facilitate
More informationOn December 27, 2017, the Lieutenant Governor signed into law several new requirements
OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following
More informationArkansas Department of Health
Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer
More informationOur Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System
Our Journey to Addressing the PA PDMP Program Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System 1 Geisinger Health System Geisinger Health System is an integrated
More informationHEALTH INFORMATION TECHNOLOGY: A POWERFUL TOOL IN ATTACKING THE OPIOID CRISIS PAUL L. UHRIG CHIEF ADMINISTRATIVE, LEGAL & PRIVACY OFFICER
HEALTH INFORMATION TECHNOLOGY: A POWERFUL TOOL IN ATTACKING THE OPIOID CRISIS PAUL L. UHRIG CHIEF ADMINISTRATIVE, LEGAL & PRIVACY OFFICER Copyright 2018 2017 by by Surescripts, LLC. All All rights reserved.
More informationMental and Behavioral Health
Mental and Behavioral Health Mental Health Poor mental health is a major source of distress, disability, and social burden. In any given year, as many as one in five adults in the United States have a
More informationFigure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,
Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, -217 1, Total Overdose Deaths Male Female 8, 7,237 6, 4, 16,849 2 21 22 23 24 36,1 25 26 27 28 29 21 211 212 213 214 215 216 217-217
More information2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS)
2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS) Overview Value Partnerships, in conjunction with the Blue Cross Pharmacy team, has created the Electronic Prescribing of Controlled
More informationPolicy Title. Control Number HR003. Exception The Scotland County Sheriff s Department is subject to a separate policy.
Purpose To ensure compliance with federal regulations as outlined under the Drug-Free Workplace Act and by the U.S. Department of Transportation; to identify the conditions by which personnel are subject
More informationSIXTY-FOURTH LEGISLATURE OF THE STATE OF WYOMING 2017 GENERAL SESSION
AN ACT relating to public health and safety; creating the Emergency Administration of Opiate Antagonist Act; providing for prescription and administration of an opiate antagonist drug as specified; granting
More informationPOLICY ON DRUGS & ABUSE
POLICY ON DRUGS & ABUSE 1 Statement of Need Nangia & Co has a strong commitment to the health, safety and welfare of its employees, their families and its customers. Widely available statistics and information
More informationState of California Department of Justice. Bureau of Narcotic Enforcement
State of California Department of Justice Bureau of Narcotic Enforcement Prescription Drugs in the U.S. At least half of all Americans take one prescription drug regularly, with one in six taking three
More informationUpdate on the Opioid Crisis
Update on the Opioid Crisis Robert A. Alldredge Jr Fort Worth Police Deputy Chief Homer Robertson Fort Worth Fire Department Assistant Chief Chris Mosley Sr. Assistant City Attorney/Section Chief Opioid
More informationPrescription Drugs: Issues in Treatment, Supervision and Case Management
Prescription Drugs: Issues in Treatment, Supervision and Case Management National Association of Drug Court Professionals Washington, DC July 16, 2013 Agenda Overview of prescription drug diversion and
More informationRole of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx
Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services
More informationChallenges for U.S. Attorneys Offices (USAO) in Opioid Cases
Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being
More informationASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED MAY 15, 2014
ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED MAY, 0 Sponsored by: Assemblyman RONALD S. DANCER District (Burlington, Middlesex, Monmouth and Ocean) Assemblyman HERB CONAWAY, JR. District
More information